vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Fat Brands, Inc (FAT). Click either name above to swap in a different company.

Fat Brands, Inc is the larger business by last-quarter revenue ($140.0M vs $77.6M, roughly 1.8× Bioceres Crop Solutions Corp.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -41.6%, a 32.0% gap on every dollar of revenue. On growth, Fat Brands, Inc posted the faster year-over-year revenue change (-2.3% vs -16.8%). Over the past eight quarters, Fat Brands, Inc's revenue compounded faster (-6.1% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

FAT Brands Inc. is an American multi-brand restaurant and sports bar franchise operator headquartered in Beverly Hills, California.

BIOX vs FAT — Head-to-Head

Bigger by revenue
FAT
FAT
1.8× larger
FAT
$140.0M
$77.6M
BIOX
Growing faster (revenue YoY)
FAT
FAT
+14.5% gap
FAT
-2.3%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
32.0% more per $
BIOX
-9.6%
-41.6%
FAT
Faster 2-yr revenue CAGR
FAT
FAT
Annualised
FAT
-6.1%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
BIOX
BIOX
FAT
FAT
Revenue
$77.6M
$140.0M
Net Profit
$-7.4M
$-58.2M
Gross Margin
46.8%
Operating Margin
9.3%
-12.4%
Net Margin
-9.6%
-41.6%
Revenue YoY
-16.8%
-2.3%
Net Profit YoY
-20.2%
-30.1%
EPS (diluted)
$-0.12
$-3.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
FAT
FAT
Q3 25
$77.6M
$140.0M
Q2 25
$146.8M
Q1 25
$60.6M
$142.0M
Q4 24
$98.8M
$145.3M
Q3 24
$93.3M
$143.4M
Q2 24
$152.0M
Q1 24
$84.0M
$152.0M
Q4 23
$140.2M
$158.6M
Net Profit
BIOX
BIOX
FAT
FAT
Q3 25
$-7.4M
$-58.2M
Q2 25
$-54.2M
Q1 25
$-1.6M
$-46.0M
Q4 24
$605.2K
$-67.4M
Q3 24
$-6.2M
$-44.8M
Q2 24
$-39.4M
Q1 24
$9.8M
$-38.3M
Q4 23
$1.2M
$-26.2M
Gross Margin
BIOX
BIOX
FAT
FAT
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Q4 23
36.7%
Operating Margin
BIOX
BIOX
FAT
FAT
Q3 25
9.3%
-12.4%
Q2 25
-10.6%
Q1 25
1.5%
-6.0%
Q4 24
14.5%
-27.1%
Q3 24
2.5%
-6.2%
Q2 24
-1.8%
Q1 24
15.7%
-0.9%
Q4 23
12.0%
-2.0%
Net Margin
BIOX
BIOX
FAT
FAT
Q3 25
-9.6%
-41.6%
Q2 25
-36.9%
Q1 25
-2.6%
-32.4%
Q4 24
0.6%
-46.4%
Q3 24
-6.6%
-31.2%
Q2 24
-25.9%
Q1 24
11.6%
-25.2%
Q4 23
0.9%
-16.5%
EPS (diluted)
BIOX
BIOX
FAT
FAT
Q3 25
$-0.12
$-3.39
Q2 25
$-3.17
Q1 25
$-0.02
$-2.73
Q4 24
$0.00
$-4.06
Q3 24
$-0.10
$-2.74
Q2 24
$-2.43
Q1 24
$0.14
$-2.37
Q4 23
$0.00
$-1.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
FAT
FAT
Cash + ST InvestmentsLiquidity on hand
$15.5M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$288.3M
$-585.8M
Total Assets
$734.9M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
FAT
FAT
Q3 25
$15.5M
Q2 25
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
Q2 24
Q1 24
$16.4M
Q4 23
$24.4M
Total Debt
BIOX
BIOX
FAT
FAT
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B
Q4 23
$1.2B
Stockholders' Equity
BIOX
BIOX
FAT
FAT
Q3 25
$288.3M
$-585.8M
Q2 25
$-536.5M
Q1 25
$345.0M
$-493.9M
Q4 24
$346.3M
$-455.7M
Q3 24
$346.0M
$-386.1M
Q2 24
$-338.6M
Q1 24
$348.5M
$-296.8M
Q4 23
$335.3M
$-255.9M
Total Assets
BIOX
BIOX
FAT
FAT
Q3 25
$734.9M
$1.2B
Q2 25
$1.2B
Q1 25
$798.2M
$1.3B
Q4 24
$835.2M
$1.3B
Q3 24
$827.3M
$1.3B
Q2 24
$1.4B
Q1 24
$836.1M
$1.4B
Q4 23
$819.5M
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
FAT
FAT
Operating Cash FlowLast quarter
$14.4M
$-14.5M
Free Cash FlowOCF − Capex
$-16.9M
FCF MarginFCF / Revenue
-12.1%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-75.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
FAT
FAT
Q3 25
$14.4M
$-14.5M
Q2 25
$-26.9M
Q1 25
$23.3M
$-13.2M
Q4 24
$-5.4M
$-10.4M
Q3 24
$5.2M
$-3.2M
Q2 24
$-14.2M
Q1 24
$-17.4M
$-28.4M
Q4 23
$21.1M
$-12.6M
Free Cash Flow
BIOX
BIOX
FAT
FAT
Q3 25
$-16.9M
Q2 25
$-29.3M
Q1 25
$-17.8M
Q4 24
$-11.0M
Q3 24
$-11.1M
Q2 24
$-24.4M
Q1 24
$-32.5M
Q4 23
$-18.0M
FCF Margin
BIOX
BIOX
FAT
FAT
Q3 25
-12.1%
Q2 25
-20.0%
Q1 25
-12.5%
Q4 24
-7.6%
Q3 24
-7.7%
Q2 24
-16.1%
Q1 24
-21.4%
Q4 23
-11.4%
Capex Intensity
BIOX
BIOX
FAT
FAT
Q3 25
1.7%
Q2 25
1.6%
Q1 25
3.2%
Q4 24
0.4%
Q3 24
5.5%
Q2 24
6.7%
Q1 24
2.7%
Q4 23
3.4%
Cash Conversion
BIOX
BIOX
FAT
FAT
Q3 25
Q2 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24
Q1 24
-1.78×
Q4 23
17.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

FAT
FAT

Restaurant Sales$96.6M69%
Royalty$21.6M15%
Factory$9.6M7%
Advertising$9.1M7%
Franchisor$1.5M1%
Other$1.5M1%

Related Comparisons